News from drug-eluting therapies in 2026

Moderators: T. Adriaenssens, A. Achim

Speakers: D. Faria, S. Zwackman, V. A. Jimenez Diaz, M. Abdelghani, A. Attinger

Summary

This session presents the latest advancements in drug-eluting therapies for 2026, including predictors of target lesion failure after drug-coated balloon treatment, clinical outcomes related to stenting length, and novel insights into sirolimus transfer evidenced by in vivo OCT imaging.

Presentations available when logged in:

Predictors of target lesion failure after drug-coated balloon treatment: a multivariable analysis
Outcomes after treatment with DCB in foreign-born vs. native-born patients
Sirolimus transfer and retention after DCB angioplasty: in vivo OCT evidence
Impact of stenting length on clinical outcomes after implantation of newer-generation DES

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

News from drug-eluting therapies in 2026

Log in or create account for free